So-Young International (NASDAQ:SY) versus CompuMed (OTCMKTS:CMPD) Critical Contrast

CompuMed (OTCMKTS:CMPD) and So-Young International (NASDAQ:SY) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, valuation, earnings and dividends.

Earnings & Valuation

This table compares CompuMed and So-Young International”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CompuMed	$5.84 million	0.77	-$30,000.00	$0.15	22.73
So-Young International	$1.49 billion	0.07	$3.00 million	$0.05	17.20

So-Young International has higher revenue and earnings than CompuMed. So-Young International is trading at a lower price-to-earnings ratio than CompuMed, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

35.3% of So-Young International shares are owned by institutional investors. 22.0% of CompuMed shares are owned by insiders. Comparatively, 16.7% of So-Young International shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares CompuMed and So-Young International’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
CompuMed	2.37%	4.54%	3.27%
So-Young International	2.41%	1.41%	1.11%

Analyst Ratings

This is a breakdown of current ratings and recommmendations for CompuMed and So-Young International, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CompuMed	0	0	0	0	0.00
So-Young International	0	1	0	0	2.00

So-Young International has a consensus target price of $0.80, indicating a potential downside of 6.99%. Given So-Young International’s stronger consensus rating and higher probable upside, analysts clearly believe So-Young International is more favorable than CompuMed.

Volatility & Risk

CompuMed has a beta of 0.35, suggesting that its stock price is 65% less volatile than the S&P 500. Comparatively, So-Young International has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500.

Summary

So-Young International beats CompuMed on 7 of the 13 factors compared between the two stocks.

About CompuMed

CompuMed, Inc., an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults. It also offers OsteoGram software that works in combination with standard or digital X-ray equipment to support osteoporosis screening, diagnosis, and therapy monitoring. In addition, the company provides mobile ECG and ultrasound solutions that provide patients with immediate access to its board-certified specialists; and medical devices. It serves organ procurement organizations, rural healthcare, and correctional healthcare industries. CompuMed, Inc. was founded in 1973 and is headquartered in Los Angeles, California.

About So-Young International

So-Young International Inc. operates an online platform for consumption healthcare services in the People's Republic of China. The company offers So-Young Mobile App that offers users medical aesthetic knowledge and experience to reach an informed medical aesthetic treatment decision and make reservations for treatment with medical professionals and medical aesthetic institutions; So-Young Beauty which provides similar interfaces and functions as the mobile app, as well as serves as additional access points to the platform; and medical aesthetic community content through its website soyoung.com. It provides content in various media formats on its online platform generated by users, including professional generated, content from in-house editorial team that shares opinions on specific new medical procedures and trends; user generated content comprising Beauty Diaries that provides details about medical institution, doctor, price, and other information on the treatment; professional user generated, contents from the medical aesthetic influencers; and doctor generated, content from doctors to generate knowledge. In addition, the company offers consumption healthcare services, including dermatology, dentistry and orthodontics, physical examinations, gynecology, and postnatal care; reservation services; and software as a service. Further, it engages in research and development, production, sales, and agency of laser and other optoelectronic medical beauty equipment; manufacture and sells light therapy device, surgical laser device and other equipment; internet information and technology advisory; online medical treatment and consultation; management consulting; internet culture; micro finance services, as well as sells cosmetics products. The company was founded in 2013 and is headquartered in Beijing, China.